Intensive treatment of acute leukemia in adults 70 years of age and older
Authors:
- Michael J. KeatingMKMichael J. Keating
- Kenneth B. McCredieKMKenneth B. McCredie
Open Access
Abstract
The results of treatment for acute leukemia since 1973 in 87 patients aged 70 years or more are summarized. The overall complete remission rate was 27/78 (35%) in acute myelogenous leukemia and 5/9 (56%) in acute lymphocytic leukemia or acute undifferentiated leukemia for cytosine arabinoside combined with either anthracyclines (rubidazone or Adriamycin [doxorubicin]) or m‐AMSA (amsacrine). The remission duration was short with a median of 33 weeks, and the median overall survival was only 6 weeks. Those patients without identifiable infection, liver enlargement, and a serum glutamic oxaloacetic transaminase < 40 U/ml constituted a more favorable subgroup. Although the complete remission rate improved further research is needed to develop effective maintenance strategies.Keywords
This publication has 15 references indexed in Scilit:
- Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.Journal of Clinical Investigation, 1985
- Difference between young and old patients in characteristics of leukemic cells: Older patients have cells growing excessively in vitro, with low antigenicity despite high HLA‐DR antigensAmerican Journal of Hematology, 1984
- A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotypeBlood, 1982
- Acute Nonlymphocytic Leukemia in the Elderly: Biology and Treatment1982
- Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BBlood, 1981
- Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemiaBlood, 1981
- Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)Blood, 1981
- A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemiaCancer, 1981
- The Therapy of Acute Granulocytic Leukemia in Patients More Than Fifty Years OldAnnals of Internal Medicine, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958